1. Diabetes reimbursement at risk in Germany

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  2. Adaptive licensing: A new approach for drug approvals

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  3. EU Transparency Directive: changes afoot on pricing and reimbursement

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  4. German drug policy puts pressure on prices in Europe

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  5. EU pharmacovigilance law comes into force

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous contributing editor

    Read more

  6. The outlook for new clinical trials legislation in Europe

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  7. Why health technology assessment is here to stay

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  8. Europe to tackle antimicrobial resistance

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  9. ADCs propelled back into the oncology spotlight

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  10. Making the most of EU funding

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more